ELICASAL OINTMENT 30G

Indications

Approved Uses

Treatment of hyperkeratotic, dry, corticosteroid-responsive inflammatory dermatoses (e.g., psoriasis) where a keratolytic is beneficial.

Dosage & Administration

Dosing by Condition

Hyperkeratotic corticosteroid-responsive dermatoses (e.g., psoriasis): apply thin layer twice daily; reassess if not controlled within 2-3 weeks

Initial Dose

Apply a thin film to the affected area once or twice daily.

Maximum Dose

No fixed maximum grams/day established; apply thin layer twice daily to affected areas for up to 21 days; use smallest amount for shortest duration, avoid large areas/occlusion

Dose Adjustment Notes

No renal/hepatic dose adjustment is required; use the smallest amount for the shortest duration, avoid large surface areas/occlusion, and reduce frequency or discontinue if significant irritation, skin atrophy, or signs of systemic corticosteroid effects occur; stop when control is achieved.

How to Take

Clean and dry affected area, apply thin layer to affected skin twice daily and rub gently; wash hands after (unless treating hands); avoid eyes/mucous membranes; do not use under occlusion unless directed

Side Effects

Common Side Effects

Application-site burning/stinging, irritation, pruritus, dryness, erythema, peeling; with prolonged/excessive use: skin atrophy, striae, telangiectasia, folliculitis, and secondary infection.

Safety & Warnings

Contraindications

Hypersensitivity to mometasone furoate, salicylic acid, or excipients; untreated bacterial, viral (e.g., herpes simplex, varicella), or fungal skin infections at the application site; rosacea; perioral dermatitis; acne vulgaris; application to ulcerated/broken skin

Drug Interactions

Drug Interactions

Avoid combining on the same area with other topical corticosteroids, other keratolytics/exfoliants (e.g., salicylic acid products, retinoids, benzoyl peroxide), or using occlusive dressings unless directed; salicylic acid may increase percutaneous absorption of co-applied topical drugs

Food Interaction

No restriction

Alcohol Interaction

Safe

Special Populations

Pregnancy

Caution

Breastfeeding

Caution

Elderly

Standard adult dosing; use with caution due to increased risk of skin atrophy in elderly patients with fragile skin

Kidney Impairment

No dose adjustment for renal impairment for topical use; use caution with large surface area/prolonged/occlusive use (higher salicylate exposure)

Storage & Patient Advice

Missed Dose

Apply when remembered; if it is close to the next dose, skip the missed dose and resume the regular schedule; do not apply extra to make up for a missed dose.

Monitoring Requirements

No routine laboratory monitoring for short courses on limited areas; clinically monitor for local adverse effects (irritation, atrophy, striae, infection) and consider HPA-axis suppression assessment if prolonged use, large surface area use, occlusion, pediatric use, or other risk factors for systemic absorption.

Pharmacology

Mechanism of Action

Mometasone furoate is a potent topical corticosteroid that activates glucocorticoid receptors to reduce inflammatory mediator production and vasodilation; salicylic acid is a keratolytic that disrupts corneocyte cohesion to promote desquamation and improve steroid penetration through hyperkeratotic skin.

Metabolism

Mometasone furoate: extensive hepatic metabolism primarily via CYP3A4; salicylic acid: hepatic metabolism mainly by conjugation (glycine to salicyluric acid and glucuronidation).

Protein Binding

Mometasone furoate: high protein binding (~98-99%); salicylic acid: moderate-to-high and concentration-dependent (~50-80%+).

Product Information

Available Dosage Forms

Ointment (30 g tube).

Composition per Dose

Each 1g of ointment contains: 1mg Mometasone Furoate (0.1% w/w) and 50mg Salicylic Acid (5% w/w).

Skin Condition

Psoriasis, Eczema

Steroid Potency

Potent

Legal Disclaimer - Al Mujtama Pharmacy The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment. Al Mujtama Pharmacy assumes no legal or medical liability for: Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist Any discrepancy between the information provided and the product's package insert or SFDA guidelines Any misuse of medication resulting from personal interpretation of the content displayed Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication. By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation. Your health is a trust - always consult your doctor first.